SHARPEN YOUR SKATES! 🙌🎉 Saturday is THE day! We’re putting the final touches on the ice, and a 3.6 km section of the #RideauCanal Skateway between Somerset and Bank will open at 8:00 am on Saturday, January 11th. #ottnews #ottawa

Excited to see my project at University of Oxford finally published at Nature Genetics ! Huge thanks to my co-authors Simon Myers Daniel Lawson Jonathan Marchini Garrett Hellenthal Lino Ferreira Sinan Shi , and the reviewers/editors. Read the publication here: nature.com/articles/s4158… 🚀🎉

Vous ne pouvez pas prendre notre pays — et vous ne pouvez pas prendre notre sport.

You can’t take our country — and you can’t take our game.

In the UKBB proteomics data I see PC1 is driven by many (~10-15%) proteins with highly correlated expression without obvious biological links e.g. DBNL, CRKL, HARS1, TWF2, YWHAQ, PPP1R2, GCC1, MSRA, CASP3, RWDD1. Can anyone point me to some literature explaining this?

Game, set, match. The only message that matters. 🇨🇦🇺🇦

Today, the United States launched a trade war against Canada: their closest partner and ally — their closest friend. Canadians are reasonable, but we will not back down from a fight. Not when our country is at stake.

Good to have you back.

Guys I made a breakthrough

This is a really, really beautiful chart Improvements in survival over time for the most common childhood cancer:

We (Deep Genomics) are hiring a statistical geneticist to develop and apply methods at the intersection of systems biology, genomic AI, and traditional genetic target discovery. CAN/US remote or hybrid, DM me with any questions! jobs.lever.co/deepgenomics/2…

NEW: Function Health acquired Ezra to merge lab testing with AI-powered full-body MRI scans. The new $499 platform offers 160+ lab tests and 22-minute scans. It’ll be exciting to watch the growing preventive care space as Function, Prenuvo, Biograph, and others make big moves.

We have reached a sale agreement with Regeneron, a leading US-based biotechnology company, to carry forward 23andMe’s mission and maintain customer privacy protections. Read more about today’s announcement here: 23and.me/3ZoX2JT

the new pope has a math degree. the new romanian president has a math phd. this is only the beginning my friend. the mathematicians are seizing control.

This is an incredible progress story An aggressive type of cancer (Philadelphia chromosome–positive acute lymphoblastic leukemia) used to carry a dismal prognosis, with 50% of patients dying in a year New therapies have transformed it to a cancer that most people are cured of

The peer-reviewed version of expansion in situ genome sequencing is now out in Science! The news is bittersweet – when we first revealed this last September, I never guessed it would be my final paper in academia, but a lot has changed. A few parting thoughts:

I’m deeply skeptical of the AI hype because I’ve seen this all before. I’ve watched Silicon Valley chase the dream of easy money from data over and over again, and they always hit a wall. Story time.

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide. Yet, we lack circulating biomarkers for systemic atherosclerosis burden. Check out our new preprint describing the development of proteomic signatures or atherosclerosis👇

LLMs will achieve AGI by making humans so stupid that surpassing us is trivial